SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 331 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,362,444 | +8.1% | 27,740 | +2.1% | 0.35% | +11.4% |
| Q2 2023 | $3,111,109 | -18.3% | 27,168 | -1.6% | 0.32% | +49.5% |
| Q1 2023 | $3,805,838 | +3.4% | 27,611 | -2.8% | 0.21% | +29.3% |
| Q4 2022 | $3,679,775 | -8.9% | 28,398 | -22.3% | 0.16% | -31.4% |
| Q3 2022 | $4,041,000 | +47.0% | 36,554 | +0.7% | 0.24% | -2.0% |
| Q2 2022 | $2,749,000 | -3.4% | 36,315 | -0.3% | 0.24% | +52.5% |
| Q1 2022 | $2,846,000 | -8.4% | 36,427 | +5.6% | 0.16% | -39.2% |
| Q4 2021 | $3,106,000 | +11.8% | 34,491 | -7.5% | 0.26% | +18.5% |
| Q1 2021 | $2,778,000 | -47.3% | 37,274 | +20.5% | 0.22% | -54.4% |
| Q4 2020 | $5,273,000 | – | 30,930 | – | 0.49% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 2,878,979 | $69,182,000 | 7.27% |
| Eventide Asset Management | 259,100 | $6,226,000 | 0.97% |
| GLADE BROOK CAPITAL PARTNERS LLC | 251,000 | $6,032,000 | 0.93% |
| IMS Capital Management | 32,215 | $774,000 | 0.91% |
| Perceptive Advisors | 350,000 | $8,413,000 | 0.88% |
| Benchmark Capital Advisors | 34,900 | $839,000 | 0.58% |
| BECK CAPITAL MANAGEMENT, LLC | 24,744 | $636,000 | 0.49% |
| SABBY MANAGEMENT, LLC | 352,100 | $8,461,000 | 0.47% |
| Hatteras Alternative Mutual Funds, LLC | 39,404 | $947,000 | 0.46% |
| Potomac Capital Management, Inc. | 22,100 | $531,000 | 0.45% |